Next 10 |
Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference PR Newswire CAMBRIDGE, Mass. , June 27, 2024 /PRNewswire/ -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purp...
2024-06-24 09:37:22 ET More on Akebia Buy Vafseo's Approval: A New Chapter For Akebia Therapeutics In Anemia Management Akebia's Vafseo Faces Grim Market Outlook (Rating Downgrade) Read the full article on Seeking Alpha For further details see: Akebia The...
Akebia Therapeutics Appoints Erik Ostrowski as Chief Financial Officer and Chief Business Officer PR Newswire CAMBRIDGE, Mass. , June 24, 2024 /PRNewswire/ -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with t...
2024-06-09 08:01:00 ET More on companies reporting earnings during the week FuelCell Energy: Consider Potential Q2 Results Miss And Korean Market Opportunities Oracle: Strong EPS Growth Expected In 2025 And 2026, Watching Q4 Margins (Rating Upgrade) Broadcom: It's To...
Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference PR Newswire CAMBRIDGE, Mass. , May 23, 2024 /PRNewswire/ -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better t...
Akebia Therapeutics to Present at the 2nd Annual HCW Bioconnect Investor Conference PR Newswire CAMBRIDGE, Mass. , May 14, 2024 /PRNewswire/ -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to b...
2024-05-09 11:57:22 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Akebia Therapeutics (NASDAQ: AKBA ) just reported results for the first quarter of 2024. Akebia Therapeutics reported earnings per share of -9 cents. This was below the an...
2024-05-09 10:54:12 ET Akebia Therapeutics, Inc. (AKBA) Q1 2024 Earnings Conference Call May 09, 2024, 8:00 AM ET Company Participants Mercedes Carrasco - Senior Director, Corporate Communications and IR John Butler - President and Chief Executive Officer Nichola...
2024-05-09 10:00:35 ET More on Health Care Select Sector SPDR XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance 16 out...
2024-05-09 07:21:26 ET More on Akebia Buy Vafseo's Approval: A New Chapter For Akebia Therapeutics In Anemia Management Akebia's Vafseo Faces Grim Market Outlook (Rating Downgrade) Akebia Q1 2024 Earnings Preview Akebia stock jumps as FDA clears renal anemia ...
News, Short Squeeze, Breakout and More Instantly...
Akebia Therapeutics Inc. Company Name:
AKBA Stock Symbol:
NASDAQ Market:
Akebia Therapeutics Inc. Website:
Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference PR Newswire CAMBRIDGE, Mass. , June 27, 2024 /PRNewswire/ -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purp...
Akebia Therapeutics Appoints Erik Ostrowski as Chief Financial Officer and Chief Business Officer PR Newswire CAMBRIDGE, Mass. , June 24, 2024 /PRNewswire/ -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with t...
Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference PR Newswire CAMBRIDGE, Mass. , May 23, 2024 /PRNewswire/ -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better t...